Laddar...
Redirecting T cells to hematological malignancies with bispecific antibodies
There is a need to improve outcomes for patients with recurrent and/or refractory hematological malignancies. Immunotherapy holds the promise to meet this need, because it does not rely on the cytotoxic mechanism of conventional therapies. Among different forms of immunotherapy, redirecting T cells...
Sparad:
| I publikationen: | Blood |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society of Hematology
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5755042/ https://ncbi.nlm.nih.gov/pubmed/29118005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-06-741058 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|